Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in WA17822

NCT00721123 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00721123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00721123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in WA17822
Lead sponsor
Hoffmann-La Roche
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2005
Completion date
May 31, 2012
Enrollment
538 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis